Imagine living with unexplained changes and health issues for nearly a decade, only to discover it's a rare disease that was, until recently, very difficult to treat and can affect nearly every aspect ...
The journal Pituitary has highlighted research led by Manel Puig, head of the Endocrine, Thyroid and Obesity Research Group ...
Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest ...
From the "pot-bellied" appearance to the flaws in the LDDST, Cushing's disease remains one of our most complex endocrine ...
Speaking about her condition, Aleksa Diaz, 30, told Newsweek: "Even if I’m physically exhausted, I can’t fall asleep." ...
ELK GROVE VILLAGE, Ill., Sept. 26, 2025 /PRNewswire/ -- Orsini, a leader in rare disease pharmacy solutions, has been chosen by Crinetics Pharmaceuticals, Inc., as a specialty pharmacy partner for ...
Cannabis use disorder (CUD) was associated with a greater than fivefold increased risk for benign tumors of major salivary glands compared to not having CUD, a new retrospective study showed.
Increased relative risks of benign major salivary gland tumors and parotid salivary gland tumors, which persist over time. HealthDay News — Cannabis use disorder (CUD) is associated with increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback